» Articles » PMID: 22347285

Toxoplasma Infection in Schizophrenia Patients: a Comparative Study with Control Group

Overview
Specialty Parasitology
Date 2012 Feb 21
PMID 22347285
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Schizophrenia is a serious, chronic, and often debilitating neuropsychiatric disorder. Its causes are still poorly understood. Besides genetic and non-genetic (environmental) factors are thought to be important as the cause of the structural and functional deficits that characterize schizophrenia. This study aimed to compare Toxoplasma gondii infection between schizophrenia patients and non-schizophrenia individuals as control group.

Methods: A case-control study was designed in Tehran, Iran during 2009-2010. Sixty-two patients with schizophrenia and 62 non-schizophrenia volunteers were selected. To ascertain a possible relationship between T. gondii infection and schizophrenia, anti-Toxoplasma IgG antibodies were detected by indirect-ELISA. Data were statistically analyzed by chi- square at a confidence level of 99%.

Results: The sero-positivity rate among patients with schizophrenia (67.7%) was significantly higher than control group (37.1) (P <0. 01).

Conclusion: A significant correlation between Toxoplasma infection and schizophrenia might be expected.

Citing Articles

Schizophrenia Etiological Factors and Their Correlation with the Imbalance of the Immune System: An Update.

Lotfi N, Rezaei N, Rastgoo E, Khodadoustan Shahraki B, Zahedi G, Jafarinia M Galen Med J. 2024; 12:e3109.

PMID: 39553412 PMC: 11568428. DOI: 10.31661/gmj.v12i.3109.


Anti-Toxoplasma gondii IgG seroprevalence in the general population in Iran: A systematic review and meta-analysis, 2000-2023.

Hamidi F, Rostami A, Hosseini S, Calero-Bernal R, Hajavi J, Ahmadi R PLoS One. 2024; 19(8):e0307941.

PMID: 39208344 PMC: 11361691. DOI: 10.1371/journal.pone.0307941.


Seroprevalence and Associated Risk Factors of in Patients Diagnosed with Schizophrenia: A Case-Control Cross Sectional Study.

Grada S, Mihu A, Oatis D, Marc C, Chicea L, Petrescu C Biomedicines. 2024; 12(5).

PMID: 38790960 PMC: 11117935. DOI: 10.3390/biomedicines12050998.


Systematic Review on the Relationship between Toxoplasmosis and Mental Disorders.

Bartolome Del Pino L, Zanon-Moreno V Actas Esp Psiquiatr. 2024; 52(2):149-160.

PMID: 38622004 PMC: 11015818. DOI: 10.62641/aep.v52i2.1658.


Associations between Infection and Multiple Sclerosis: A Case-Control Seroprevalence Study.

Shahra M, Keshavarz H, Sahraeian M, Shojaee S, Heidari A, Alimi R Iran J Parasitol. 2023; 18(2):165-171.

PMID: 37583639 PMC: 10423903. DOI: 10.18502/ijpa.v18i2.13182.


References
1.
Powell H, Gibbs Jr C, Lorenzo A, LAMPERT P, Gajdusek D . Toxoplasmosis of the central nervous system in the adult. Electron microscopic observations. Acta Neuropathol. 1978; 41(3):211-6. DOI: 10.1007/BF00690438. View

2.
Flegr J, Kodym P, Tolarova V . Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol. 2000; 53(1):57-68. DOI: 10.1016/s0301-0511(00)00034-x. View

3.
Torrey E, Bartko J, Lun Z, Yolken R . Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2006; 33(3):729-36. PMC: 2526143. DOI: 10.1093/schbul/sbl050. View

4.
Torrey E . Are we overestimating the genetic contribution to schizophrenia?. Schizophr Bull. 1992; 18(2):159-70. DOI: 10.1093/schbul/18.2.159. View

5.
Wang H, Wang G, Li Q, Shu C, Jiang M, Guo Y . Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand. 2006; 114(1):40-8. DOI: 10.1111/j.1600-0447.2006.00780.x. View